← Open Payments lookup

COLLEEN MONAGHAN: Open Payments

NPI 1255192563 · EASTON, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,287 in 32 payments from 18 companies in 2025. Trend: 2023 $99 · 2024 $1,357 · 2025 $1,287

Long term medical supply or device loan: $682Food & beverage: $605
CompanyPaymentsAmount
Novartis Pharmaceuticals Corporation9$720
Regeneron Healthcare Solutions, Inc.3$91
Takeda Pharmaceuticals U.S.A., Inc.2$56
Daiichi Sankyo Inc.2$49
AstraZeneca Pharmaceuticals LP2$40
Janssen Biotech, Inc.2$38
Caris MPI, Inc.1$36
Exelixis Inc.1$34
Genmab U.S., Inc.1$33
PharmaEssentia USA Corporation1$33

Products named: KISQALI, LIBTAYO, Enhertu, LYNOZYFIC, MI CANCER SEEK, CABOMETYX, Epkinly, BESREMI.

Industry payments across MD — which companies pay providers there.